Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation.
about
Cell Culture, Technology: Enhancing the Culture of Diagnosing Human DiseasesWharton's Jelly-Derived Mesenchymal Stromal Cells as a Promising Cellular Therapeutic Strategy for the Management of Graft-versus-Host DiseaseInternational Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials.Strategies for Achieving Measurement Assurance for Cell Therapy Products.An official American Thoracic Society workshop report: stem cells and cell therapies in lung biology and diseases.Proceedings: international regulatory considerations on development pathways for cell therapies.CDCP1 identifies a CD146 negative subset of marrow fibroblasts involved with cytokine production.Generation of clinical grade human bone marrow stromal cells for use in bone regenerationA reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs.Freshly thawed and continuously cultured human bone marrow-derived mesenchymal stromal cells comparably ameliorate allergic airways inflammation in immunocompetent mice.ASTM international workshop on standards and measurements for tissue engineering scaffolds.Position Paper of the European Society of Cardiology Working Group Cellular Biology of the Heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.Manufacturing Cells for Clinical UseResearch using Mesenchymal Stem/Stromal Cells: quality metric towards developing a reference material.Bistable Epigenetic States Explain Age-Dependent Decline in Mesenchymal Stem Cell HeterogeneityMorphological features of IFN-γ-stimulated mesenchymal stromal cells predict overall immunosuppressive capacity.Are clinical trials with mesenchymal stem/progenitor cells too far ahead of the science? Lessons from experimental hematologyStem Cell-Based Therapy in Idiopathic Pulmonary Fibrosis.Prospects and progress in cell therapy for acute respiratory distress syndrome.The exciting prospects of new therapies with mesenchymal stromal cells.The translation of cell-based therapies: clinical landscape and manufacturing challenges.Low oxygen tension reveals distinct HOX codes in human cord blood-derived stromal cells associated with specific endochondral ossification capacities in vitro and in vivo.Controlled delivery of SDF-1α and IGF-1: CXCR4(+) cell recruitment and functional skeletal muscle recovery.Fibroblasts and Mesenchymal Stromal/Stem Cells Are Phenotypically IndistinguishableMesenchymal stem cells in the osteosarcoma microenvironment: their biological properties, influence on tumor growth, and therapeutic implications.Epigenetic quality check - how good are your mesenchymal stromal cells?Methods for Long-Term Storage of Murine Bone Marrow-Derived Mesenchymal Stem Cells.Potency Analysis of Mesenchymal Stromal Cells Using a Combinatorial Assay Matrix Approach.
P2860
Q26748487-D0CBEB72-C354-4FF0-8A23-DC7BEB5DCF67Q28083027-9CEE597B-BBDD-4736-AD86-0A273A05CA4EQ30488740-0A59922B-82D3-46FF-A3A8-AA0EB9A407A2Q30761058-763AF2A4-9804-4366-9614-02F7FD10A9C6Q33783282-61CC7399-15A8-4FCF-8E48-C51C810626FDQ33975643-E88872D0-42AB-4D72-A217-AAD3EF177ED1Q34282531-5D217277-90A8-4191-9E40-893AD36A520CQ34717689-6F0B6EFB-D5EF-4A75-8753-FB5670CEBCC9Q34979619-B607AF5A-67FE-4446-9FBF-9C305C200685Q34985576-B8854982-DF7E-4F6F-ABB7-7D245012215EQ35665325-FAF9F900-19C1-4240-9A78-D482988D9ED8Q36950112-FD2DC555-B1DF-427B-93AA-942D6598C5FCQ37016190-A3F02DB8-F8DD-43C1-B4D1-1FEF78703445Q37038263-18C41954-5C5B-48E1-8F34-10C7F221BBA7Q37090955-DABE744A-3FB1-4A9C-A7B1-820D655F74B3Q37696475-8B459E4D-6EE4-4160-8382-5BFAFFA55D07Q37737100-8E2F3204-CF16-48E5-9D86-44803763AB8DQ38237590-58C34F9A-A12A-4B34-A748-B584F5EFDD54Q38432028-389F4E11-8C61-42C5-BFAA-456F53DB5088Q38917280-3E9798FF-3AB2-4804-97BD-55BAF4DE6974Q38987828-74787909-6CA6-41D7-B7F4-292BAADAC0E6Q39063831-9AC6907B-6EC0-4B1D-B13F-BFDA245939CCQ39744028-C6BF3880-D998-46C3-A4BE-7746FF4C06B6Q40654214-D4100283-FF3B-4C4D-AAE5-5AE317C61C77Q41699059-B451A432-9A15-4842-8533-764928ED0A87Q47701410-A2B92074-EB53-476C-A671-2197EA3317CCQ51273018-BF1F72E7-8DE2-4D1D-B78C-296E22DDFFD3Q52902808-1829ACE2-4733-4D7A-9A2F-CC003796E0B5Q55387791-2BC5EE26-AF0C-4579-BD33-C66C72D9501F
P2860
Soliciting strategies for developing cell-based reference materials to advance mesenchymal stromal cell research and clinical translation.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Soliciting strategies for deve ...... arch and clinical translation.
@ast
Soliciting strategies for deve ...... arch and clinical translation.
@en
type
label
Soliciting strategies for deve ...... arch and clinical translation.
@ast
Soliciting strategies for deve ...... arch and clinical translation.
@en
prefLabel
Soliciting strategies for deve ...... arch and clinical translation.
@ast
Soliciting strategies for deve ...... arch and clinical translation.
@en
P2093
P2860
P356
P1476
Soliciting strategies for deve ...... arch and clinical translation.
@en
P2093
Christopher Mason
Dan J Weiss
Darwin Prockop
David F Stroncek
Glyn Stacey
Mahendra S Rao
Peiman Hematti
Robert Deans
P2860
P304
P356
10.1089/SCD.2013.0591
P577
2014-03-10T00:00:00Z